Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Clasificación en acciones #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Precio por acción
$1.02
Capitalización bursátil
$131.45M
Cambio (1 día)
-0.62%
Cambio (1 año)
-37.92%
País
TW
Comercio Pharmosa Biopharm Inc. (6875)

Categoría

Historial de desdoblamientos de acciones de Pharmosa Biopharm Inc. (6875)
La acción Pharmosa Biopharm Inc. (símbolo: 6875) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 24, 2026.
Una acción 6875 comprada antes de Aug 24, 2026 equivaldría hoy a 0 acciones 6875.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH